EMILY FISHER: Open Payments
NPI 1447436209 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 31 payments from 13 companies in 2025. Trend: 2023 $530 · 2024 $322 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $273 |
| Ferring Pharmaceuticals Inc. | 3 | $86 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| Laborie Medical Technologies Corp. | 2 | $41 |
| Olympus America Inc. | 2 | $34 |
| Dendreon Pharmaceuticals LLC | 1 | $29 |
| Procept Biorobotics Corporation | 1 | $27 |
| 180 Medical, Inc. | 1 | $25 |
| Ambu Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $20 |
Products named: BOTOX, ADSTILADRIN, GEMTESA, LUPRON DEPOT, iTIND System, PROVENGE, AQUABEAM ROBOTIC SYSTEM, Optilume BPH Drug Coated Balloon Catheter.
Industry payments across TX — which companies pay providers there.
